Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Junior Gold Miners (GDXJ) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

VanEck Junior Gold MinersTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

VanEck Junior Gold Miners vs ImmunityBio Inc. Common Stock — how do they compare? VanEck Junior Gold Miners trades at $114.43 (market cap $8.22B), while ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Junior Gold Miners for 41 Days and ImmunityBio Inc. Common Stock for 1 Days on average.

GDXJIBRX
Market Cap
$8.22B$10.51B
Volume
3,212,19810,445,785
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$156.19$11.55
52-Week Low
$87.56$1.98
Typical Hold Time
41 Days1 Days
Enterprise Value
—$10.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Junior Gold Miners

GDXJ, the VanEck Junior Gold Miners ETF, trades at $114.43, up 4.85% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF is undergoing significant rebalancing, with multiple junior mining companies like Sinda Ltd. and Hemlo Mining Corp. being added to the fund as of September 2026, which may impact liquidity and composition. Key financial ratios are not applicable as this is an ETF tracking a basket of stocks.

The outlook is mixed; recent gold price strength above $4,400 (24/7 Wall Street, August 16, 2026) supports miner ETFs, but GDXJ's bearish technicals and institutional selling (Amundi reduced its stake by 50.5% as per Defense World, August 6, 2026) suggest caution. Risks include gold price volatility and the high-risk nature of junior miners. Investment appeal hinges on gold's momentum versus the ETF's technical weakness.

ImmunityBio Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GDXJ
100% Buy0% Sell
Avg holding period · 41 Days
IBRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About VanEck Junior Gold Miners

GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.

Read more on GDXJ →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →